Gyula Győri, Scientific Director, and Dr. Botond Szűcs, Chief Biologist, spent three days in Washington DC at the end of September at the invitation of the Federal Motor Carrier Safety Administration (FMCSA).
The U.S. Department of Transportation in Washington D.C.
Members of the delegation met with Associate Administrator for Policy and Program Development Larry Minor and Transportation Specialist Rich Clemente. Also present at the meeting were PHARMAFLIGHT's US business partner, ATA-Associates, CEO Bob Swint, ex-NASA engineer, and Richard Cook, Deputy CEO. The meeting focused on reviewing the details of a future grant proposal and the participants discussed the feasibility of using PHARMAFLIGHT's measurement methodology within the FMCSA's existing and operational fatigue management program.